PMMA

1. 2026-10-19issueIssued info_card
2. 2026-10-19issueIssued notice
3. 2026-09-24srcEffect of Some Psychoactive Drugs Used as 'Legal Highs' on Brain Neurotransmitters
4. 2026-09-24srcThe PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications
5. 2026-09-24srcSynthesis and organic impurity profiling of 4-methoxymethamphetamine hydrochloride and its precursors
6. 2026-09-24srcLiquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs
7. 2026-09-24srcPKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice
8. 2026-09-24srcMonoamine transporter and receptor interaction profiles of a new series of designer cathinones
9. 2026-09-24srcBehavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats
10. 2026-09-24srcStudies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration
11. 2026-09-24srcStudies on Para-Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications
12. 2026-09-24srcMDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology
13. 2026-09-24srcAmphetamine Derivatives as Monoamine Oxidase Inhibitors
14. 2026-09-24srcCellular Uptake of Psychostimulants - Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?
15. 2026-09-24srcNovel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling
16. 2026-09-24srcDeaths from exposure to paramethoxymethamphetamine in Alberta and British Columbia, Canada: a case series
17. 2026-09-24srcStimulus properties of PMMA: effect of optical isomers and conformational restriction
18. 2026-09-24srcPMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA
19. 2026-09-24srcNew designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry
20. 2026-09-24srcA fatal paramethoxymethamphetamine intoxication
21. 2026-09-24srcN-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats
22. 2026-09-24srcA preliminary behavioral investigation of PMMA, the 4-methoxy analog of methamphetamine
23. 2026-09-24srcSchedules of Controlled Substances: Placement of PMMA in Schedule I
24. 2026-09-24srcPMA and PMMA - Alcohol and Drug Foundation Australia
25. 2026-09-24srcPara-Methoxy-N-methylamphetamine (PMMA) - HandWiki
26. 2026-09-24srcCouncil decides PMMA should be placed under control
27. 2026-09-24srcPMMA/PMA - DrugFacts UK
28. 2026-09-04issueIssued emergency
29. 2026-09-04issueIssued info_card
30. 2026-09-04issueIssued notice
31. 2026-06-04proposal30 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
32. 2026-06-04publicationPublication — backfill
33. 2026-04-25revisionRevision 1
34. 2026-04-25absenceSearched ClinicalTrials.gov for "para-methoxymethamphetamine PMMA" — no results
35. 2026-04-25genGeneration — pipeline-v5pipeline-v5
36. 2026-04-25rungeneration run

The same entries, as forms: six forms.